Evidence map›Paper›PMID 31877773›Full record

ArticleNutrients2019

Leptin, Ghrelin, and Leptin/Ghrelin Ratio in Critically Ill Patients.

Yaseen M Arabi, Dunia Jawdat, Hasan M Al-Dorzi, Hani Tamim, Waleed Tamimi, Abderrezak Bouchama, Musharaf Sadat, Lara Afesh, Mashan L Abdullah, Walid Mashaqbeh and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Ghrelin as an Anti-Sepsis Peptide: Review.Frontiers in immunology · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Yaseen M ArabiIntensive Care Department, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia.ORCID 0000-0001-5735-6241
Dunia JawdatCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11426, Saudi Arabia.
Hasan M Al-DorziIntensive Care Department, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia.ORCID 0000-0002-3772-8949
Hani TamimCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11426, Saudi Arabia.
Waleed TamimiCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11426, Saudi Arabia.
Abderrezak BouchamaIntensive Care Department, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia.
Musharaf SadatIntensive Care Department, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia.
Lara AfeshKing Abdullah International Medical Research Center, Riyadh 11426, Saudi Arabia.
Mashan L AbdullahCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11426, Saudi Arabia.ORCID 0000-0002-4628-1536
Walid MashaqbehCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11426, Saudi Arabia.ORCID 0000-0002-4145-1890
Maram SakhijaIntensive Care Department, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia.
Abdulaziz Al-DawoodIntensive Care Department, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences · SAKing Abdullah International Medical Research Center · SA

Funding

King Abdulaziz City for Science and Technology AT 32-25 KACST.
6 · The paper itself

Abstract

The objective of this study was to evaluate leptin, ghrelin, and leptin/ghrelin ratio in critically ill patients and association of leptin/ghrelin ratio with outcomes. This is a sub-study of the PermiT trial (ISRCTN68144998). A subset of 72 patients who were expected to stay >14 days in the Intensive care unit were enrolled. Blood samples were collected on days 1, 3, 5, 7, and 14. Samples were analyzed for leptin and active ghrelin in addition to other hormones. Baseline leptin/ghrelin ratio was calculated, and patients were stratified into low and high leptin/ghrelin ratio based on the median value of 236. There was a considerable variation in baseline leptin level: Median 5.22 ng/mL (Q1, Q3: 1.26, 17.60). Ghrelin level was generally low: 10.61 pg/mL (Q1, Q3: 8.62, 25.36). Patients with high leptin/ghrelin ratio compared to patients with low leptin/ghrelin ratio were older, had higher body mass index and more likely to be diabetic. There were no differences in leptin/ghrelin ratio between patients who received permissive underfeeding and standard feeding. Multivariable logistic regression analysis showed that age and body mass index were significant independent predictors of high leptin-ghrelin ratio. Leptin-ghrelin ratio was not associated with 90-day mortality or other outcomes. Age and body mass index are predictors of high leptin/ghrelin ratio. Leptin/ghrelin ratio is not affected by permissive underfeeding and is not associated with mortality.

Indexed as

Critical IllnessAdultAgedBiomarkersFemaleGhrelinHumansLeptinLogistic ModelsMaleMiddle AgedMultivariate AnalysisYoung AdultBiomarkersGhrelinLeptinadipokinesBMIcritical illnessenergy restrictioninflammatory markersobesity

Identifiers

PMID31877773
PMCPMC7020071
OpenAlexW2995653023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.